Beijing
Beijing
Beijing, Xicheng, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, chronic hepatitis B virus infection, epithelial neoplasm, hepatitis, hepatitis B virus infection, hepatocellular carcinoma, infectious disease, liver disorder, neoplasm, viral hepatitis, viral infectious disease | Not yet recruiting | Not stated | 2026-08-28 | NCT07780357 | |
| Postoperative Infections and Immune Profiles in Patients Undergoing LVAD Implantation | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Active, not recruiting | Not stated | 2025-12-01 | NCT07255716 | |
| Clinical Classification of MAFLD Based Liver Biopsy | Metabolic Dysfunction Associated Steatotic Liver Disease; Metabolic Dysfunction-associated Steatohepatitis (MASH) | Not yet recruiting | Not stated | 2025-02-12 | NCT06795646 |